Literature DB >> 1885974

Radiation-induced meningiomas: experience at the Mount Sinai Hospital and review of the literature.

M J Harrison1, D E Wolfe, T S Lau, R J Mitnick, V P Sachdev.   

Abstract

From the records of The Mount Sinai Hospital, seven cases which met established criteria for radiation-induced meningiomas were identified. This represents the largest series of radiogenic meningiomas documented in North America and includes both intracranial and intraspinal tumors. The records and pathological specimens were reviewed and these data analyzed with other cases retrieved from the world literature. This study reveals that radiation-induced meningiomas can be categorized into three groups based on the amount of radiation administered: 1) low dose; 2) moderate dose and miscellaneous; and 3) high dose. The overwhelming majority of cases had received low-dose irradiation (800 rad) to the scalp for tinea capitis and the second largest group resulted from high-dose irradiation for primary brain tumors (greater than 2000 rad). The unique features distinguishing radiation-induced meningiomas from other meningiomas are reviewed. Although histologically atypical tumors were common in this series, overt malignancy was not encountered. The preoperative management of these lesions should include angiography to evaluate for large-vessel occlusive vasculopathy, a known association of meningiomas induced by high-dose irradiation. Given the propensity these tumors possess for recurrence, a wide bony and dural margin is recommended at surgical resection.

Entities:  

Mesh:

Year:  1991        PMID: 1885974     DOI: 10.3171/jns.1991.75.4.0564

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  32 in total

Review 1.  Pediatric meningiomas: a single-center experience with 15 consecutive cases and review of the literature.

Authors:  Marcelo Volpon Santos; Luciano Furlanetti; Elvis Terci Valera; Maria Sol Brassesco; Luiz Gonzaga Tone; Ricardo Santos de Oliveira
Journal:  Childs Nerv Syst       Date:  2012-06-06       Impact factor: 1.475

Review 2.  Update on meningiomas.

Authors:  Santosh Saraf; Bridget J McCarthy; J Lee Villano
Journal:  Oncologist       Date:  2011-10-25

Review 3.  Radiation induced meningioma with a short latent period following high dose cranial irradiation - case report and literature review.

Authors:  Ajay Choudhary; Satyajit Pradhan; Mohammad Fakhrul Huda; Sureswar Mohanty; Mohan Kumar
Journal:  J Neurooncol       Date:  2005-11-15       Impact factor: 4.130

4.  Double trouble: a tale of two radio-treatments.

Authors:  Ebere Sunny Ogbonnaya; Nikolay Peev; Sanjoy Nagaraja; Ronan Dardis
Journal:  BMJ Case Rep       Date:  2014-09-19

5.  Growth retardation and bilateral cataracts followed by anaplastic meningioma 23 years after high-dose cranial and whole-body irradiation for acute lymphoblastic leukemia: case report and review of the literature.

Authors:  Alexei I Korenkov; Hans G Imhof; Sebastian Brandner; Ethan Taub; Pia U Huguenin; Michael R Gaab; Yasuhiro Yonekawa
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

6.  Olfactory neuroblastoma following treatment for pituitary adenoma.

Authors:  Kyung-Jae Park; Shin-Hyuk Kang; Hoon-Gab Lee; Yong-Gu Chung
Journal:  J Neurooncol       Date:  2008-08-05       Impact factor: 4.130

Review 7.  Epidemiology and etiology of intracranial meningiomas: a review.

Authors:  M Bondy; B L Ligon
Journal:  J Neurooncol       Date:  1996-09       Impact factor: 4.130

8.  High-dose radiation-induced meningiomas in elderly.

Authors:  M Salvati; L Cervoni; R Caruso; R Delfini; F M Gagliardi
Journal:  Neurosurg Rev       Date:  1996       Impact factor: 3.042

Review 9.  Treatment of meningioma: an update.

Authors:  Anthony L D'Ambrosio; Jeffrey N Bruce
Journal:  Curr Neurol Neurosci Rep       Date:  2003-05       Impact factor: 5.081

Review 10.  Meningiomas of the cranial base.

Authors:  R Desai; J Bruce
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.